Minimizing Blood Loss Using Tranexamic Acid in Patients Undergoing Spine Surgery .
Single Dose of Tranexamic Acid Effectively Reduces Blood Loss in Patients Undergoing Spine Surgery: A Prospective Randomized Controlled Trial.
World Neurosurg . 2023 Jul;175:e964-e968.Sixty patients undergoing spine surgery were randomized to receive either tranexamic acid (TXA; n=30) or a placebo (n=30). Outcomes of interest included hemoglobin level, intraoperative blood loss, drainage volume, total blood loss, units of blood transfused, operative time, incidence of adverse events, and length of stay. Intraoperative blood loss was significantly lower in the TXA group. All other outcomes were similar between the two groups.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics